Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 2209292Generated: November 1, 2026

tert-Butyl 2-oxo-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)spiro[indoline-3,4'-piperidine]-1'-carboxylate → 1,4,4-Trimethyl-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,1-benzoxazin-2-one

https://huagongshe.com/reaction/2209292

Reaction equation

Participants

RoleNameHCIDCharge
Reactanttert-Butyl 2-oxo-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)spiro[indoline-3,4'-piperidine]-1'-carboxylateHCID 92133768—
Reactant7-Bromo-1,4,4-trimethyl-3,1-benzoxazin-2-oneHCID 117843176—
Product1,4,4-Trimethyl-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,1-benzoxazin-2-oneHCID 123433187—

Reaction Steps

Following the procedure described for intermediate 7.33 (Step 2), starting from 7-bromo-1,4,4-trimethyl-1H-benzo[d][1,3]oxazin-2(4H)-one 7.38 (540 mg), 560 mg of 1,4,4-trimethyl-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzo[d][1,3]oxazin-2(4H)-one 7.40 was obtained. LCMS [M+H]+: 318.12.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS09376441B2
Source datasetuspto-grants-2016_06
ORD IDord-bf837b757c2a47638ca9a440e05347e8
Source noteuspto-grants-2016_06